US75886F1075
US75886F1075
Regeneron Pharmaceuticals, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 76.86B EUR | 64.31B EUR | 81.14B EUR | 81.6B EUR |
Enterprise Value | 68.56B EUR | 64.56B EUR | 80.88B EUR | 81.19B EUR |
Valuation Multiples | ||||
Trailing P/E | 18.46x | 14.86x | 18.34x | 22.08x |
Forward P/E | 12.11x | -- | -- | -- |
Price to Sales | 4.95x | 4.14x | 5.44x | 7.21x |
Price to Book | 2.36x | 2.03x | 2.58x | 2.61x |
EV/Revenue | 4.41x | 4.16x | 5.42x | 7.18x |
EV/EBITDA | 14.58x | 11.87x | 15.77x | 19.88x |
Price to FCF (P/FCF) | 25.07x | 17.99x | 21.4x | 27.28x |
EV/FCF | 22.37x | 18.06x | 21.34x | 27.14x |
FCF Yield | 3.99% | 5.56% | 4.67% | 3.67% |